The new injectable weight-loss drug reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo.
Weill Cornell Medicine researchers have determined the full-length structure and function of a blood pressure-regulating hormone receptor, which may enable better drug targeting of the receptor for diseases such as hypertension and heart failure.
Alistair Hayden, a professor of practice in public and ecosystem health and a former division chief at the California Governor’s Office of Emergency Services, comments on Canadian wildfire smoke reaching the U.S. and how to improve a national response to future smoke waves.
The award funds innovative but inherently risky research endeavors that have the potential to overturn existing scientific paradigms or create new ones.
The secret to cellular youth may depend on keeping the nucleolus – a condensed structure inside the nucleus of a cell – small, according to Weill Cornell Medicine investigators.
For the first time, scientists have tracked the dispersion of the Oropouche virus in the Brazilian Amazon region, an important first step to control future outbreaks of a disease with more than 100,000 reported cases since the 1960s.
Working with week-old zebrafish larva, researchers at Weill Cornell Medicine and colleagues decoded how the connections formed by a network of neurons in the brainstem guide the fishes’ gaze.
The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine researchers.
